When and How to Use Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction or Chronic Kidney Disease
Publication date: April 2021Source: Canadian Journal of Cardiology, Volume 37, Issue 4Author(s): Eileen O’Meara, Subodh Verma
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
More News: Canada Health | Cardiology | Chronic Kidney Disease | Heart | Heart Failure | Sodium | Urology & Nephrology